Tracking movement and voice changes in FTD
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study uses smart devices to measure how FTD affects movement and speech. It aims to find better ways to track the disease over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years or older.
- You must have a diagnosis of possible or probable FTD (a type of frontotemporal degeneration).
- You must speak and read English fluently.
- You must have a caregiver or study partner who can help with study tasks.
- You must not have more than 5 falls per month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a wearable sensor device that remotely tracks physical activity and movement patterns in people with frontotemporal dementia (a type of brain condition affecting thinking and behavior). The goal is to see if this technology can help doctors monitor disease progression and catch changes early without frequent clinic visits.
This study follows people with frontotemporal dementia (FTLD) and related conditions, and collects health and (for some people) body fluid information, to understand how these illnesses change over time. It may help researchers track disease signs and find better ways to measure progression.
This study looks at testing (including brain scans) to figure out what type of frontotemporal dementia or related language/speech condition a person has. It may help by making diagnoses more accurate, which can guide better care.
This study collects health information from people with neurodegenerative diseases, some family members, and healthy controls to help researchers better understand these conditions. It may help future diagnosis and research, and participation may include noninvasive checks and other procedures depending on your situation.
This study tests a non-invasive brain stimulation technique called tACS (transcranial alternating current stimulation) in people with frontotemporal dementia. The goal is to see if it can improve symptoms like behavior and language problems.
This study tracks changes in people with Parkinson's disease, other movement disorders, or cognitive decline to find better ways to measure disease progression.
Hear when a new Frontotemporal Lobar Degeneration (FTLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.